Immuneering CorporationIMRXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-55.08M
↓ 66% below average
Average (5y)
$-33.21M
Historical baseline
Range
High:$-4.46M
Low:$-55.08M
CAGR
+65.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-55.08M | -11.7% |
| 2023 | $-49.31M | -10.0% |
| 2022 | $-44.84M | -45.1% |
| 2021 | $-30.91M | -110.7% |
| 2020 | $-14.67M | -228.8% |
| 2019 | $-4.46M | - |